Xcellerant Ventures
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Jetstream
  • Contact
Select Page
Xcellerant Ventures Backs CRISPR QC in Series A and Commercial Expansion

Xcellerant Ventures Backs CRISPR QC in Series A and Commercial Expansion

by Xcellerant Ventures | Jan 5, 2024 | Portfolio Company News

Originally posted on Business Wire: https://www.businesswire.com/news/home/20240104480597/en/Xcellerant-Ventures-Backs-CRISPR-QC-in-Series-A-and-Commercial-Expansion SAN DIEGO–(BUSINESS WIRE)–CRISPR QC, a biotechnology start-up based in San Diego, is...
Unraveling the Value Chain of CRISPR QC: Safeguarding the Future of Gene Editing

Unraveling the Value Chain of CRISPR QC: Safeguarding the Future of Gene Editing

by Xcellerant Ventures | Nov 10, 2023 | Portfolio Company News

This blog was origionally posted on the Digital Journal and can be viewed here: https://www.digitaljournal.com/tech-science/unraveling-the-value-chain-of-crispr-qc-safeguarding-the-future-of-gene-editing We now live in a world where scientists can edit genes, and...
CRISPR QC’s Game-Changing Role in Gene Editing and Biotechnology

CRISPR QC’s Game-Changing Role in Gene Editing and Biotechnology

by Xcellerant Ventures | Jul 28, 2023 | Portfolio Company News

Blog origionally posted on New York Weekly: https://nyweekly.com/science/crispr-qcs-game-changing-role-in-gene-editing-and-biotechnology/ Gene editing allows scientists to modify a cell to change its function while retaining its natural genome. The process...
Paragraf Acquires CRISPR-Chip Developer Cardea Bio, Accelerating CRISPR QC’s Business Opportunity

Paragraf Acquires CRISPR-Chip Developer Cardea Bio, Accelerating CRISPR QC’s Business Opportunity

by Xcellerant Ventures | May 3, 2023 | Portfolio Company News

Article origionally posted on Business Wire: https://www.businesswire.com/news/home/20230503005191/en/Paragraf-Acquires-CRISPR-Chip-Developer-Cardea-Bio-Accelerating-CRISPR-QC%E2%80%99s-Business-Opportunity SAN DIEGO–(BUSINESS WIRE)–Today, CRISPR QC...
CRISPR QC Announces Formation of Scientific Advisory Board with Rodolphe Barrangou, Gene Dantsker, Jared Carlson-Stevermer Joining; Kiana Aran to Lead

CRISPR QC Announces Formation of Scientific Advisory Board with Rodolphe Barrangou, Gene Dantsker, Jared Carlson-Stevermer Joining; Kiana Aran to Lead

by Xcellerant Ventures | Apr 10, 2023 | Portfolio Company News

Press release origionally published on Business Wire: https://www.businesswire.com/news/home/20230410005125/en/CRISPR-QC-Announces-Formation-of-Scientific-Advisory-Board-with-Rodolphe-Barrangou-Gene-Dantsker-Jared-Carlson-Stevermer-Joining-Kiana-Aran-to-Lead SAN...
« Older Entries
Next Entries »

Recent Posts

  • Democratizing health care: There’s an app for that
  • Nanodropper® Now Operating as Mu Medical™, Planned Expansion of Precision Eyecare Platform with Bedo Solutions and Viseon Labs
  • DeepLook Medical Expands Precision Imaging Capabilities Through Strategic Partnerships and Expert Advisors, Integrating Innovative Solutions into Widely Used Platforms to Deliver Critical Insights at
  • DeepLook Medical and NHS Oxford University UK announce new study
  • Scottsdale’s Xcellerant Ventures Launches Jetstream Venture Fund, Expanding Access to VC-Style Investing

Recent Comments

No comments to show.
  • Portfolio
  • Team
  • About
  • Invest
  • News
  • Contact
  • Privacy Policy
© Xcellerant Ventures 2023